EMEA (Europe, Middle East and Africa) Overactive Bladder Treatment Market Report 2017

October 2017 | 118 pages | ID: E262B906EF9EN
QYResearch

Abstracts

In this report, the EMEA Overactive Bladder Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Overactive Bladder Treatment for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Overactive Bladder Treatment market competition by top manufacturers/players, with Overactive Bladder Treatment sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Astellas Pharma
• Pfizer
• Teva Pharmaceutical Industries Limited
• Allergan
• Medtronic
• Mylan
• Endo International
• Hisamitsu Pharmaceutical
• Sanofi
• Aurobindo Pharma Limited
• Apotex
• Cogentix Medical

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into

• Anticholinergic- Solifenacin
• Oxybutynin
• Fesoterodine
• Darifenacin
• Mirabegron
• BOTOX
• Neurostimulation

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Overactive Bladder Treatment for each application, including

• Idiopathic Bladder Overactivity
• Neurogenic Bladder Overactivity

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Overactive Bladder Treatment Market Report 2017

1 OVERACTIVE BLADDER TREATMENT OVERVIEW

1.1 Product Overview and Scope of Overactive Bladder Treatment
1.2 Classification of Overactive Bladder Treatment
  1.2.1 EMEA Overactive Bladder Treatment Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Overactive Bladder Treatment Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Anticholinergic- Solifenacin
  1.2.4 Oxybutynin
  1.2.5 Fesoterodine
  1.2.6 Darifenacin
  1.2.7 Mirabegron
  1.2.8 BOTOX
  1.2.9 Neurostimulation
1.3 EMEA Overactive Bladder Treatment Market by Application/End Users
  1.3.1 EMEA Overactive Bladder Treatment Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Idiopathic Bladder Overactivity
  1.3.3 Neurogenic Bladder Overactivity
1.4 EMEA Overactive Bladder Treatment Market by Region
  1.4.1 EMEA Overactive Bladder Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Overactive Bladder Treatment (2012-2022)
  1.5.1 EMEA Overactive Bladder Treatment Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Overactive Bladder Treatment Revenue and Growth Rate (2012-2022)

2 EMEA OVERACTIVE BLADDER TREATMENT COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Overactive Bladder Treatment Market Competition by Players/Manufacturers
  2.1.1 EMEA Overactive Bladder Treatment Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Overactive Bladder Treatment Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Overactive Bladder Treatment Sale Price by Players (2012-2017)
2.2 EMEA Overactive Bladder Treatment (Volume and Value) by Type/Product Category
  2.2.1 EMEA Overactive Bladder Treatment Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Overactive Bladder Treatment Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Overactive Bladder Treatment Sale Price by Type (2012-2017)
2.3 EMEA Overactive Bladder Treatment (Volume) by Application
2.4 EMEA Overactive Bladder Treatment (Volume and Value) by Region
  2.4.1 EMEA Overactive Bladder Treatment Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Overactive Bladder Treatment Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Overactive Bladder Treatment Sales Price by Region (2012-2017)

3 EUROPE OVERACTIVE BLADDER TREATMENT (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Overactive Bladder Treatment Sales and Value (2012-2017)
  3.1.1 Europe Overactive Bladder Treatment Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Overactive Bladder Treatment Revenue and Growth Rate (2012-2017)
3.2 Europe Overactive Bladder Treatment Sales and Market Share by Type
3.3 Europe Overactive Bladder Treatment Sales and Market Share by Application
3.4 Europe Overactive Bladder Treatment Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Overactive Bladder Treatment Sales Volume by Countries (2012-2017)
  3.4.2 Europe Overactive Bladder Treatment Revenue by Countries (2012-2017)
  3.4.3 Germany Overactive Bladder Treatment Sales and Growth Rate (2012-2017)
  3.4.4 France Overactive Bladder Treatment Sales and Growth Rate (2012-2017)
  3.4.5 UK Overactive Bladder Treatment Sales and Growth Rate (2012-2017)
  3.4.6 Russia Overactive Bladder Treatment Sales and Growth Rate (2012-2017)
  3.4.7 Italy Overactive Bladder Treatment Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Overactive Bladder Treatment Sales and Growth Rate (2012-2017)

4 MIDDLE EAST OVERACTIVE BLADDER TREATMENT (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Overactive Bladder Treatment Sales and Value (2012-2017)
  4.1.1 Middle East Overactive Bladder Treatment Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Overactive Bladder Treatment Revenue and Growth Rate (2012-2017)
4.2 Middle East Overactive Bladder Treatment Sales and Market Share by Type
4.3 Middle East Overactive Bladder Treatment Sales and Market Share by Application
4.4 Middle East Overactive Bladder Treatment Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Overactive Bladder Treatment Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Overactive Bladder Treatment Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Overactive Bladder Treatment Sales and Growth Rate (2012-2017)
  4.4.4 Israel Overactive Bladder Treatment Sales and Growth Rate (2012-2017)
  4.4.5 UAE Overactive Bladder Treatment Sales and Growth Rate (2012-2017)
  4.4.6 Iran Overactive Bladder Treatment Sales and Growth Rate (2012-2017)

5 AFRICA OVERACTIVE BLADDER TREATMENT (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Overactive Bladder Treatment Sales and Value (2012-2017)
  5.1.1 Africa Overactive Bladder Treatment Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Overactive Bladder Treatment Revenue and Growth Rate (2012-2017)
5.2 Africa Overactive Bladder Treatment Sales and Market Share by Type
5.3 Africa Overactive Bladder Treatment Sales and Market Share by Application
5.4 Africa Overactive Bladder Treatment Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Overactive Bladder Treatment Sales Volume by Countries (2012-2017)
  5.4.2 Africa Overactive Bladder Treatment Revenue by Countries (2012-2017)
  5.4.3 South Africa Overactive Bladder Treatment Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Overactive Bladder Treatment Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Overactive Bladder Treatment Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Overactive Bladder Treatment Sales and Growth Rate (2012-2017)

6 EMEA OVERACTIVE BLADDER TREATMENT MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Astellas Pharma
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Overactive Bladder Treatment Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Astellas Pharma Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Overactive Bladder Treatment Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Teva Pharmaceutical Industries Limited
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Overactive Bladder Treatment Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Teva Pharmaceutical Industries Limited Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Allergan
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Overactive Bladder Treatment Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Allergan Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Medtronic
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Overactive Bladder Treatment Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Medtronic Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Mylan
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Overactive Bladder Treatment Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Mylan Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Endo International
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Overactive Bladder Treatment Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Endo International Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Hisamitsu Pharmaceutical
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Overactive Bladder Treatment Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Hisamitsu Pharmaceutical Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Sanofi
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Overactive Bladder Treatment Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Sanofi Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Aurobindo Pharma Limited
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Overactive Bladder Treatment Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Aurobindo Pharma Limited Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Apotex
6.12 Cogentix Medical

7 OVERACTIVE BLADDER TREATMENT MANUFACTURING COST ANALYSIS

7.1 Overactive Bladder Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Overactive Bladder Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Overactive Bladder Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Overactive Bladder Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA OVERACTIVE BLADDER TREATMENT MARKET FORECAST (2017-2022)

11.1 EMEA Overactive Bladder Treatment Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Overactive Bladder Treatment Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Overactive Bladder Treatment Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Overactive Bladder Treatment Price and Trend Forecast (2017-2022)
11.2 EMEA Overactive Bladder Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Overactive Bladder Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Overactive Bladder Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Overactive Bladder Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Overactive Bladder Treatment Sales Forecast by Type (2017-2022)
11.7 EMEA Overactive Bladder Treatment Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Overactive Bladder Treatment
Figure EMEA Overactive Bladder Treatment Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Overactive Bladder Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Anticholinergic- Solifenacin Product Picture
Figure Oxybutynin Product Picture
Figure Fesoterodine Product Picture
Figure Darifenacin Product Picture
Figure Mirabegron Product Picture
Figure BOTOX Product Picture
Figure Neurostimulation Product Picture
Figure EMEA Overactive Bladder Treatment Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Overactive Bladder Treatment by Application in 2016
Figure Idiopathic Bladder Overactivity Examples
Table Key Downstream Customer in Idiopathic Bladder Overactivity
Figure Neurogenic Bladder Overactivity Examples
Table Key Downstream Customer in Neurogenic Bladder Overactivity
Figure EMEA Overactive Bladder Treatment Market Size (Million USD) by Region (2012-2022)
Figure Europe Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Overactive Bladder Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Overactive Bladder Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Africa Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Overactive Bladder Treatment Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Overactive Bladder Treatment Sales Volume and Growth Rate (2012-2022)
Figure EMEA Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Overactive Bladder Treatment Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Overactive Bladder Treatment Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Overactive Bladder Treatment Sales Share by Players (2012-2017)
Figure 2016 Overactive Bladder Treatment Sales Share by Players
Figure 2017 Overactive Bladder Treatment Sales Share by Players
Figure EMEA Overactive Bladder Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Overactive Bladder Treatment Revenue (Million USD) by Players (2012-2017)
Table EMEA Overactive Bladder Treatment Revenue Share by Players (2012-2017)
Table 2016 EMEA Overactive Bladder Treatment Revenue Share by Players
Table 2017 EMEA Overactive Bladder Treatment Revenue Share by Players
Table EMEA Overactive Bladder Treatment Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Overactive Bladder Treatment Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Overactive Bladder Treatment Sales Share by Type (2012-2017)
Figure Sales Market Share of Overactive Bladder Treatment by Type (2012-2017)
Figure EMEA Overactive Bladder Treatment Sales Market Share by Type (2012-2017)
Table EMEA Overactive Bladder Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Overactive Bladder Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Overactive Bladder Treatment by Type in 2016
Table EMEA Overactive Bladder Treatment Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Overactive Bladder Treatment Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Overactive Bladder Treatment Sales Share by Application (2012-2017)
Figure Sales Market Share of Overactive Bladder Treatment by Application (2012-2017)
Figure EMEA Overactive Bladder Treatment Sales Market Share by Application in 2016
Table EMEA Overactive Bladder Treatment Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Overactive Bladder Treatment Sales Share by Region (2012-2017)
Figure Sales Market Share of Overactive Bladder Treatment by Region (2012-2017)
Figure EMEA Overactive Bladder Treatment Sales Market Share in 2016
Table EMEA Overactive Bladder Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Overactive Bladder Treatment Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Overactive Bladder Treatment by Region (2012-2017)
Figure EMEA Overactive Bladder Treatment Revenue Market Share Regions in 2016
Table EMEA Overactive Bladder Treatment Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Overactive Bladder Treatment Revenue and Growth Rate (2012-2017)
Table Europe Overactive Bladder Treatment Sales (K MT) by Type (2012-2017)
Table Europe Overactive Bladder Treatment Market Share by Type (2012-2017)
Figure Europe Overactive Bladder Treatment Market Share by Type in 2016
Table Europe Overactive Bladder Treatment Sales (K MT) by Application (2012-2017)
Table Europe Overactive Bladder Treatment Market Share by Application (2012-2017)
Figure Europe Overactive Bladder Treatment Market Share by Application in 2016
Table Europe Overactive Bladder Treatment Sales (K MT) by Countries (2012-2017)
Table Europe Overactive Bladder Treatment Sales Market Share by Countries (2012-2017)
Figure Europe Overactive Bladder Treatment Sales Market Share by Countries (2012-2017)
Figure Europe Overactive Bladder Treatment Sales Market Share by Countries in 2016
Table Europe Overactive Bladder Treatment Revenue (Million USD) by Countries (2012-2017)
Table Europe Overactive Bladder Treatment Revenue Market Share by Countries (2012-2017)
Figure Europe Overactive Bladder Treatment Revenue Market Share by Countries (2012-2017)
Figure Europe Overactive Bladder Treatment Revenue Market Share by Countries in 2016
Figure Germany Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure France Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure UK Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Overactive Bladder Treatment Sales (K MT) by Type (2012-2017)
Table Middle East Overactive Bladder Treatment Market Share by Type (2012-2017)
Figure Middle East Overactive Bladder Treatment Market Share by Type (2012-2017)
Table Middle East Overactive Bladder Treatment Sales (K MT) by Applications (2012-2017)
Table Middle East Overactive Bladder Treatment Market Share by Applications (2012-2017)
Figure Middle East Overactive Bladder Treatment Sales Market Share by Application in 2016
Table Middle East Overactive Bladder Treatment Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Overactive Bladder Treatment Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Overactive Bladder Treatment Sales Volume Market Share by Countries in 2016
Table Middle East Overactive Bladder Treatment Revenue (Million USD) by Countries (2012-2017)
Table Middle East Overactive Bladder Treatment Revenue Market Share by Countries (2012-2017)
Figure Middle East Overactive Bladder Treatment Revenue Market Share by Countries (2012-2017)
Figure Middle East Overactive Bladder Treatment Revenue Market Share by Countries in 2016
Figure Saudi Arabia Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Overactive Bladder Treatment Sales (K MT) by Type (2012-2017)
Table Africa Overactive Bladder Treatment Sales Market Share by Type (2012-2017)
Figure Africa Overactive Bladder Treatment Sales Market Share by Type (2012-2017)
Figure Africa Overactive Bladder Treatment Sales Market Share by Type in 2016
Table Africa Overactive Bladder Treatment Sales (K MT) by Application (2012-2017)
Table Africa Overactive Bladder Treatment Sales Market Share by Application (2012-2017)
Figure Africa Overactive Bladder Treatment Sales Market Share by Application (2012-2017)
Table Africa Overactive Bladder Treatment Sales Volume (K MT) by Countries (2012-2017)
Table Africa Overactive Bladder Treatment Sales Market Share by Countries (2012-2017)
Figure Africa Overactive Bladder Treatment Sales Market Share by Countries (2012-2017)
Figure Africa Overactive Bladder Treatment Sales Market Share by Countries in 2016
Table Africa Overactive Bladder Treatment Revenue (Million USD) by Countries (2012-2017)
Table Africa Overactive Bladder Treatment Revenue Market Share by Countries (2012-2017)
Figure Africa Overactive Bladder Treatment Revenue Market Share by Countries (2012-2017)
Figure Africa Overactive Bladder Treatment Revenue Market Share by Countries in 2016
Figure South Africa Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Table Astellas Pharma Overactive Bladder Treatment Basic Information List
Table Astellas Pharma Overactive Bladder Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Astellas Pharma Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Astellas Pharma Overactive Bladder Treatment Sales Market Share in EMEA (2012-2017)
Figure Astellas Pharma Overactive Bladder Treatment Revenue Market Share in EMEA (2012-2017)
Table Pfizer Overactive Bladder Treatment Basic Information List
Table Pfizer Overactive Bladder Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Overactive Bladder Treatment Sales Market Share in EMEA (2012-2017)
Figure Pfizer Overactive Bladder Treatment Revenue Market Share in EMEA (2012-2017)
Table Teva Pharmaceutical Industries Limited Overactive Bladder Treatment Basic Information List
Table Teva Pharmaceutical Industries Limited Overactive Bladder Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Limited Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Limited Overactive Bladder Treatment Sales Market Share in EMEA (2012-2017)
Figure Teva Pharmaceutical Industries Limited Overactive Bladder Treatment Revenue Market Share in EMEA (2012-2017)
Table Allergan Overactive Bladder Treatment Basic Information List
Table Allergan Overactive Bladder Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Allergan Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Allergan Overactive Bladder Treatment Sales Market Share in EMEA (2012-2017)
Figure Allergan Overactive Bladder Treatment Revenue Market Share in EMEA (2012-2017)
Table Medtronic Overactive Bladder Treatment Basic Information List
Table Medtronic Overactive Bladder Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Medtronic Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Medtronic Overactive Bladder Treatment Sales Market Share in EMEA (2012-2017)
Figure Medtronic Overactive Bladder Treatment Revenue Market Share in EMEA (2012-2017)
Table Mylan Overactive Bladder Treatment Basic Information List
Table Mylan Overactive Bladder Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mylan Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Mylan Overactive Bladder Treatment Sales Market Share in EMEA (2012-2017)
Figure Mylan Overactive Bladder Treatment Revenue Market Share in EMEA (2012-2017)
Table Endo International Overactive Bladder Treatment Basic Information List
Table Endo International Overactive Bladder Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Endo International Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Endo International Overactive Bladder Treatment Sales Market Share in EMEA (2012-2017)
Figure Endo International Overactive Bladder Treatment Revenue Market Share in EMEA (2012-2017)
Table Hisamitsu Pharmaceutical Overactive Bladder Treatment Basic Information List
Table Hisamitsu Pharmaceutical Overactive Bladder Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hisamitsu Pharmaceutical Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Hisamitsu Pharmaceutical Overactive Bladder Treatment Sales Market Share in EMEA (2012-2017)
Figure Hisamitsu Pharmaceutical Overactive Bladder Treatment Revenue Market Share in EMEA (2012-2017)
Table Sanofi Overactive Bladder Treatment Basic Information List
Table Sanofi Overactive Bladder Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Sanofi Overactive Bladder Treatment Sales Market Share in EMEA (2012-2017)
Figure Sanofi Overactive Bladder Treatment Revenue Market Share in EMEA (2012-2017)
Table Aurobindo Pharma Limited Overactive Bladder Treatment Basic Information List
Table Aurobindo Pharma Limited Overactive Bladder Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Aurobindo Pharma Limited Overactive Bladder Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Aurobindo Pharma Limited Overactive Bladder Treatment Sales Market Share in EMEA (2012-2017)
Figure Aurobindo Pharma Limited Overactive Bladder Treatment Revenue Market Share in EMEA (2012-2017)
Table Apotex Overactive Bladder Treatment Basic Information List
Table Cogentix Medical Overactive Bladder Treatment Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Overactive Bladder Treatment
Figure Manufacturing Process Analysis of Overactive Bladder Treatment
Figure Overactive Bladder Treatment Industrial Chain Analysis
Table Raw Materials Sources of Overactive Bladder Treatment Major Manufacturers in 2016
Table Major Buyers of Overactive Bladder Treatment
Table Distributors/Traders List
Figure EMEA Overactive Bladder Treatment Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Overactive Bladder Treatment Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Overactive Bladder Treatment Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Overactive Bladder Treatment Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Overactive Bladder Treatment Sales Market Share Forecast by Region (2017-2022)
Table EMEA Overactive Bladder Treatment Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Overactive Bladder Treatment Revenue Market Share Forecast by Region (2017-2022)
Table Europe Overactive Bladder Treatment Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Overactive Bladder Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Europe Overactive Bladder Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Overactive Bladder Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Overactive Bladder Treatment Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Overactive Bladder Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Overactive Bladder Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Overactive Bladder Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Overactive Bladder Treatment Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Overactive Bladder Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Africa Overactive Bladder Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Overactive Bladder Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Overactive Bladder Treatment Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Overactive Bladder Treatment Sales Market Share Forecast by Type (2017-2022)
Table EMEA Overactive Bladder Treatment Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Overactive Bladder Treatment Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources